Sentinel lymph node biopsy in colon cancer: A prospective multicenter trial

Annals of Surgery

Volumn 245, Issue 6, 2007, Pages 858-863

  Bembenek, Andreas E ^a   Rosenberg, Robert ^b   Wagler, Elke ^c   Gretschel, Stephan ^a   Sendler, Andreas ^b   Siewert, Joerg Ruediger ^b   Nährig, Jörg ^o   Witzigmann, Helmut ^c   Hauss, Johann ^c   Knorr, Christian ^d   Dimmler, Arno ^o   Gröne, Jörn ^e   Buhr, Heinz Johannes ^e   Haier, Jörg ^f   Herbst, Hermann ^f   Tepel, Juergen ^g   Siphos, Bence ^g   Kleespies, Axel ^h   Koenigsrainer, Alfred ⁱ   Stoecklein, Nikolas H ^j   Horstmann, Olaf ^k   Grützmann, Robert ^l   Imdahl, Andreas ^m   Svoboda, Daniel ⁿ   Wittekind, Christian ^c   Schneider, Wolfgang ^a   Wernecke, Klaus Dieter ^e   Schlag, Peter M ^a,e   more..

^a Section of Pathology   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^k UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^l UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ UNIVERSITY HOSPITAL MARBURG   (Germany)

^o TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER PATIENT; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION;

EID: 34249284844     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000250428.46656.7e     Document Type: Article

References (35)

1. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol. 2001;8:44-47.
2. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
3. Bilchik AJ, Giuliano AE, Essner R, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am. 1998;4:351-358.
4. Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol. 2000;7:120-124.
5. Bilchik AJ, Nora DT, Sobin LH, et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol. 2003;21:668-672.
6. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg. 2006;191:305-310.
7. Bilchik AJ, Saha S, Tsioulias GJ, et al. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol. 2001;8:82-85.
8. Read T, Fleshman JW, Caushaj PF. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis Colon Rectum. 2005;48:80-85.
9. Fleig BW, Curley S, Lucci A, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2001;182:707-712.
10. Merrie AEH, van Rij AM, Phillips LV, et al. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum. 2001;44:410-417.
11. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240:624-630.
12. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol. 1998;69:212-218.
13. Hermanek P, Hutter RV, Sobin LH, et al. International Union Against Cancer: classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668-2673.
14. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors. New York: Wiley-Liss, 2002.
15. Agresti A, ed. Categorical Data Analysis. New York: Wiley, 1990.
16. Broderick-Villa G, Amr D, Haigh PI, et al. Ex vivo lymphatic mapping: a technique to improve pathologic staging in colorectal cancer. Am Surg. 2004;70:937-941.
17. Bell SW, Mourra N, Flejou JF, et al. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum. 2005;48:74-79.
18. Read TE, Mutch MG, Chang BW, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg. 2002;195:33-40.
19. Wong JH, Steineman S, Caldena C, et al. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg. 2001;233:512-521.
20. Bembenek A, Schneider U, Gretschel S, et al. Optimization of staging in colon cancer using sentinel lymph node biopsy. Der Chirurg. 2005;75:761-766.
21. Bembenek A, Schneider U, Gretschel S, et al. Detection of lymph-node micrometastases and isolated tumor cells in sentinel and non-sentinel lymph nodes of colon-cancer patients. World J Surg. 2005;29:1172-1175.
22. Bilchik AJ, Nora D, Tollenaar AEM, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer. 2002;18:977-985.
23. Rosenberg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis. 2004;19:430-437.
24. Fisher ER, Colangelo L, Wieand S, et al. Lack of influence of cytokeratine-positive mini micrometastases in 'negative node' patients with colorectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Projects Protocols R-01 and C-01. Dis Colon Rectum. 2003;46:1021-1026.
25. Noura S, Yamamoto H, Miyake Y, et al. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res. 2002;8:759-767.
26. Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol. 2001;8:303-304.
27. Haboubi NY, Abdalla SA, Amini S, et al. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis. 1998;13:99-102.
28. Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5. 2. Clin Cancer Res. 1999;5:2068.
29. Greenson JK, Craig EI, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:563-569.
30. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage 2 colon cancer. Ann Surg Oncol. 2000;7:601-608.
31. Broll R, Schauer V, Schimmelpennig H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas. Dis Colon Rectum. 1997;40:1465-1471.
32. Turner RR, Nora DT, Trocha SD, et al. Colorectal carcinoma nodal staging: frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med. 2003;127:673-679.
33. Diaz NM, Cox CE, Ebert M, et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004;28:1641-1645.
34. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878-883.
35. Berger AV, Davis DW, Tellez C, et al. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Res. 2005;65: 11185-11192.